
EDESA BIOTECH, INC.
EDESA BIOTECH, INC. (EDSA)
WebsitePrice
Market cap
Next catalystFirst U.S. sites expected to begin enrollment in Q1 2027EB06 — Phase 2 nonsegmental vitiligo · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved